Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Restraints Impact Analysis * High Therapy Cost & Limited Reimbursement Semaglutide ranked among the costliest chronic therapies in obesity care, at USD 1,300 per month in 2025
For example: Semaglutide Ozempic : Approved for type 2 diabetes Wegovy : Approved for chronic weight management Tirzepatide Mounjaro : Approved for type 2 diabetes Zepbound : Approved for chronic weight management Some plans may cover both diabetes and weight management medications, while others may only cover one and not the other
and do some light exercise
Semaglutide works by stimulating the pancreas to produce additional insulin, increasing the stomach's emptying time, and signaling to the brain a feeling of fullness
Whey protein is the most well-researched option, offering a complete amino acid profile and high leucine content to support muscle preservation
